Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin specific peptidase 17 like family member 3 (USP17L3) is a cysteine-type deubiquitinating enzyme that removes conjugated ubiquitin from substrate proteins to regulate diverse cell processes, including protein stability, cell proliferation, apoptosis, cell cycle progression, cell migration, and response to cytokines and chemokines. Induction of USP17L3 has been observed in response to inflammatory and migratory cues (e.g., chemokines like CXCL12 and IL-8) in immune and cancer cells, where it is required for both directional and random migration by regulating cytoskeletal rearrangements and the localization of small GTPases such as Ras, RhoA, Rac1, and Cdc42. It has been identified as a regulator downstream of cytokine and chemokine signaling and is implicated in processes relevant to inflammation and metastatic cancer[1][3][8]. Genetic associations with developmental disorders have also been reported[3].
Removal of conjugated ubiquitin from substrate proteins to regulate their stability and function, affecting cell cycle, migration, and signaling pathways[3][8][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin specific peptidase 17 like family member 3 (USP17L3).